Resumen

CHALEM, Monique et al. Clinical practice guideline for the prevention, diagnosis, and treatment of glucocorticoid-induced osteoporosis. Colombian Association of Rheumatology, 2023. Rev.Colomb.Reumatol. [online]. 2024, vol.31, n.3, pp.365-379.  Epub 01-Feb-2024. ISSN 0121-8123.  https://doi.org/10.1016/j.rcreu.2023.06.003.

The use of glucocorticoids 1s the most frequent cause of osteoporosis and osteoporotic fractures. Considering that glucocorticoid-induced osteoporosis (GIOP) is an underestimated and generally untreated problem, the Bone Metabolism study group of the Colombian Association of Rheumatology decided to create this Clinical Practice Guideline (CPG) in order to support rheumatologists and other specialists in the country who use this type of medication to manage inflammatory and autoimmune conditions, with recommendations on prevention, diagnosis, and treatment of GIOP. The recommendations presented here were constructed following the GRADE-ADOLOPMENT methodology. The American College of Rheumatology guideline, Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis, was selected as the source for updating the literature searches. The development of this CPG also included the participation of clinical experts from different specialties, patients, and the EpiThink Health Consulting technical-methodological team.

Palabras clave : Osteoporosis; Glucocorticoids; Practice guideline; Treatment.

        · resumen en Español     · texto en Español | Inglés     · Español ( pdf ) | Inglés ( pdf )